# Euronet Worldwide, Inc.: overview

EEFT · Nasdaq · CIK 1029199 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/eeft.md) · [Financials](/companies/eeft/financials.md) · [Filings](/companies/eeft/filings.md) · [Insiders](/companies/eeft/insiders.md)

Latest reported revenue: [$1.11bn](/filings/0001554855-26-001702.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:Revenues, accession 0001554855-26-001702).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,099](/filings/0001554855-25-001937.md) | [1,047 d](/filings/0001554855-26-000131.md) | [916](/filings/0001554855-26-000931.md) | [1,074](/filings/0001554855-26-001702.md) | [1,146](/filings/0001554855-25-001937.md) | [1,109 d](/filings/0001554855-26-000131.md) | [1,012](/filings/0001554855-26-000931.md) | [1,108](/filings/0001554855-26-001702.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [16.6%](/filings/0001554855-25-001937.md) | [11.7% d](/filings/0001554855-26-000131.md) | [8.2%](/filings/0001554855-26-000931.md) | [14.8%](/filings/0001554855-26-001702.md) | [17.0%](/filings/0001554855-25-001937.md) | [9.1% d](/filings/0001554855-26-000131.md) | [7.1%](/filings/0001554855-26-000931.md) | [12.4%](/filings/0001554855-26-001702.md) |
| Net margin | % | [13.8%](/filings/0001554855-25-001937.md) | [4.3% d](/filings/0001554855-26-000131.md) | [4.2%](/filings/0001554855-26-000931.md) | [9.1%](/filings/0001554855-26-001702.md) | [10.6%](/filings/0001554855-25-001937.md) | [4.6% d](/filings/0001554855-26-000131.md) | [3.7%](/filings/0001554855-26-000931.md) | [7.0%](/filings/0001554855-26-001702.md) |
| Diluted EPS | $ per share | [3.21](/filings/0001554855-25-001937.md) | not reported | [0.85](/filings/0001554855-26-000931.md) | [2.27](/filings/0001554855-26-001702.md) | [2.75](/filings/0001554855-25-001937.md) | not reported | [0.83](/filings/0001554855-26-000931.md) | [1.71](/filings/0001554855-26-001702.md) |
| Free cash flow | $m | [415 d](/filings/0001554855-25-001937.md) | [46.1 d](/filings/0001554855-26-000131.md) | [(21.7)](/filings/0001554855-26-000931.md) | [149 d](/filings/0001554855-26-001702.md) | [161 d](/filings/0001554855-25-001937.md) | [146 d](/filings/0001554855-26-000131.md) | [(151)](/filings/0001554855-26-000931.md) | [112 d](/filings/0001554855-26-001702.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,996](/filings/0001213900-24-016204.md) | [3,359](/filings/0001213900-25-017068.md) | [3,688](/filings/0001554855-26-000131.md) | [3,990](/filings/0001554855-26-000131.md) | [4,244](/filings/0001554855-26-000131.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [6.1%](/filings/0001213900-24-016204.md) | [11.5%](/filings/0001213900-25-017068.md) | [11.7%](/filings/0001554855-26-000131.md) | [12.6%](/filings/0001554855-26-000131.md) | [12.5%](/filings/0001554855-26-000131.md) |
| Net margin | % | [2.4%](/filings/0001213900-24-016204.md) | [6.9%](/filings/0001213900-25-017068.md) | [7.6%](/filings/0001554855-26-000131.md) | [7.7%](/filings/0001554855-26-000131.md) | [7.3%](/filings/0001554855-26-000131.md) |
| Diluted EPS | $ per share | [1.32](/filings/0001213900-24-016204.md) | [4.41](/filings/0001213900-25-017068.md) | [5.50](/filings/0001554855-26-000131.md) | [6.45](/filings/0001554855-26-000131.md) | [6.84](/filings/0001554855-26-000131.md) |
| Free cash flow | $m | [314](/filings/0001213900-24-016204.md) | [644](/filings/0001213900-25-017068.md) | [549](/filings/0001554855-26-000131.md) | [616](/filings/0001554855-26-000131.md) | [434](/filings/0001554855-26-000131.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/eeft/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $244.7m | 3,343,707 |  | Reduced −165,440 |
| [BANK OF MONTREAL /CAN/](/funds/927971.md) | 2026-06-30 | $162.2m | 2,215,823 |  | Added +302,419 |
| [TURTLE CREEK ASSET MANAGEMENT INC.](/funds/1484148.md) | 2026-06-30 | $124.4m | 1,699,473 |  | Reduced −147,567 |
| [REINHART PARTNERS, LLC.](/funds/1080298.md) | 2026-06-30 | $119.1m | 1,627,141 |  | Added +136,613 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $116.1m | 1,586,695 |  | Reduced −136,409 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $115.6m | 1,579,153 |  | Reduced −81,207 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $115.2m | 1,574,400 | Call | Unchanged |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $108.2m | 1,477,808 |  | Reduced −206,383 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $102.1m | 1,394,910 |  | Added +180,982 |
| [Jupiter Topco LLC](/funds/2146052.md) | 2026-06-30 | $98.2m | 1,341,881 |  | Not compared |

## Recent filings

[All 1,073 filings](/companies/eeft/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-04 | 16:02 ET | [10-Q](/filings/0001554855-26-001702.md) | Quarterly report, period 2026-06-30 | 0001554855-26-001702 |
| 2026-07-30 | 08:00 ET | [8-K](/filings/0001554855-26-001642.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001554855-26-001642 |
| 2026-05-22 | 13:52 ET | [8-K](/filings/0001554855-26-001112.md) | 5.07 Shareholder vote results | 0001554855-26-001112 |
| 2026-05-20 | 10:05 ET | [8-K](/filings/0001554855-26-001090.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001554855-26-001090 |
| 2026-05-07 | 16:29 ET | [10-Q](/filings/0001554855-26-000931.md) | Quarterly report, period 2026-03-31 | 0001554855-26-000931 |
| 2026-04-29 | 08:16 ET | [8-K](/filings/0001554855-26-000809.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001554855-26-000809 |
| 2026-04-28 | 16:39 ET | [8-K](/filings/0001554855-26-000791.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001554855-26-000791 |
| 2026-04-13 | 17:38 ET | [DEF 14A](/filings/0001554855-26-000595.md) | Proxy statement, period 2025-12-31 | 0001554855-26-000595 |
| 2026-02-26 | 17:24 ET | [10-K](/filings/0001554855-26-000131.md) | Annual report, period 2025-12-31 | 0001554855-26-000131 |
| 2026-02-12 | 08:11 ET | [8-K](/filings/0001554855-26-000072.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001554855-26-000072 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001554855-26-000131.md), filed Feb 26, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/2f498036-4528-442a-85c8-ada10801668b)

## About the filer

- CIK: 1029199
- Tickers: EEFT
- Exchange: Nasdaq
- SIC code: 6099 Functions Related To Depository Banking, NEC
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 08:16 ET. No prices; not investment advice.